Tender detail

Clinical trial management services for the COMBOSEQ phase III study

Summary

Fondazione IRCCS Istituto Nazionale dei Tumori is procuring contract research organization services to manage the multicentre randomized COMBOSEQ phase III clinical trial on treatment sequencing for metastatic renal cell carcinoma. The estimated contract value is €2,024,000. The notice provides for a post-award accession clause of up to 300% for consortium entities, including the foundation.

Reference number
BD9E35E8AD
Buyer
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Country
Italy (ITA)
Procedure
Open procedure
CPV
75122000 Administrative healthcare services
Deadline
2026-11-24
Status
Open
Contract subject
Services
Estimated value
2 024 000,00 EUR
Source
ITA_ANAC

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.